Interleukin-6 identified as an important factor in hypoxia- and aldehyde dehydrogenase-based gefitinib adaptive resistance in non-small cell lung cancer cells

Gefitinib resistance and relapse of the disease were the greatest challenges facing clinical therapy of non-small-cell lung cancer (NSCLC). Of note, regarding the hypoxia condition in solid tumor tissues in vivo, roles of hypoxia in gefitinib adaptive resistance and its association with lung cancer...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Lett
Main Authors: An, Shi-Min, Lei, Hui-Min, Ding, Xu-Ping, Sun, Fan, Zhang, Chun, Tang, Ya-Bin, Chen, Hong-Zhuan, Shen, Ying, Zhu, Liang
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2017
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5588073/
https://ncbi.nlm.nih.gov/pubmed/28927099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6613
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items